Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Total Liabilities came in at $220.2 million in Q2 2026, up 2.47% year-over-year from $214.9 million in Q2 2025, and down 1.21% quarter-over-quarter from $222.9 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Total Liabilities for 17 consecutive years, with $220.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Liabilities rose 2.47% year-over-year to $220.2 million in Q2 2026; TTM through Jun 2026 was $220.2 million, a 2.47% increase from a year earlier, with the FY2025 full-year figure at $222.2 million, up 3.56% from the prior year.
  • Total Liabilities was $220.2 million for Q2 2026 at Lemaitre Vascular, down from $222.9 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $222.9 million in Q1 2026 and troughed at $34.7 million in Q1 2022.
  • A 5-year average of $110.8 million and a median of $45.7 million in 2024 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities slumped 50.37% in 2022 and soared 393.5% in 2025, its largest moves.
  • Over 5 years, Total Liabilities stood at $42.3 million in 2022, then climbed by 15.62% to $48.9 million in 2023, then surged by 338.9% to $214.5 million in 2024, then rose by 3.56% to $222.2 million in 2025, then dropped by 0.89% to $220.2 million in 2026.
  • The last three Total Liabilities figures came in at $220.2 million (Q2 2026), $222.9 million (Q1 2026), and $222.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 57.45 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 2.58 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 42.46 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 23.94 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 20.04 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 3.14 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 9.50 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 3.83 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 3.51 Bn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 220.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 220.21 Mn
Mar 31, 2026 222.90 Mn
Dec 31, 2025 222.17 Mn
Sep 30, 2025 219.15 Mn
Jun 30, 2025 214.91 Mn
Mar 31, 2025 208.43 Mn
Dec 31, 2024 214.53 Mn
Sep 30, 2024 45.95 Mn
Jun 30, 2024 43.55 Mn
Mar 31, 2024 45.45 Mn
Dec 31, 2023 48.88 Mn
Sep 30, 2023 45.38 Mn
Jun 30, 2023 42.64 Mn
Mar 31, 2023 40.70 Mn
Dec 31, 2022 42.28 Mn
Sep 30, 2022 40.80 Mn
Jun 30, 2022 41.39 Mn
Mar 31, 2022 34.67 Mn
Dec 31, 2021 38.65 Mn
Sep 30, 2021 40.43 Mn